Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Globe Biomedical
AddedFeb 18, 2024
UpdatedJun 18, 2026
Globe Biomedical

Globe Biomedical

Globe Biomedical: Developing wearable tech for glaucoma patients since 2017, based in California.

HQ
Murrieta, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded in 2017 and headquartered in Riverside, California, Globe Biomedical focuses on developing wearable technology for glaucoma patients. The company's core mission is to leverage AI and machine learning to preserve vision. Their flagship product, Blink, is a continuous ocular healthcare platform that enables individuals to monitor their eye health and overall wellness through smart frames.

Notable affiliated people include the dedicated team of engineers and medical professionals who drive innovation at Globe Biomedical. The company has garnered attention for its pioneering use of AI/ML in ocular health, significantly impacting the way glaucoma is monitored and managed. Through its advanced wearable technology, Globe Biomedical aims to enhance the quality of life for glaucoma patients globally.

Globe Biomedical - Similar Companies

International Biomedical Devices logo

International Biomedical Devices

aperturectc.com

Glaukos logo

Glaukos

glaukos.com

Zeit Medical logo

Zeit Medical

zeitmedical.com

Bigfoot Biomedical logo

Bigfoot Biomedical

Kiffik Biomedical logo

Kiffik Biomedical

kiffik.com

Pulsewave logo

Pulsewave

VisionQuest Biomedical logo

VisionQuest Biomedical

Blinktbi logo

Blinktbi

blinktbi.com

Biosenix logo

Biosenix

Optiscan Biomedical logo

Optiscan Biomedical

optiscancorp.com

Bioxytech Retina logo

Bioxytech Retina

bioxytech.com

G-Tech Medical logo

G-Tech Medical

gtechmedical.com

GlucoVista logo

GlucoVista

glucovista.com

Advanced Biomedics logo

Advanced Biomedics

AugMI Labs logo

AugMI Labs

Globe Biomedical - Quick Facts

Who are Globe Biomedical's competitors?

Companies similar to Globe Biomedical include International Biomedical Devices, Glaukos, Zeit Medical and Bigfoot Biomedical.

When was Globe Biomedical founded?

Globe Biomedical was founded in 2017.

Where is Globe Biomedical's headquarters located?

Globe Biomedical's headquarters is located in Murrieta, CA, US.

When was Globe Biomedical's last funding round?

Globe Biomedical's most recent funding round was for $714.8k (USD) in March 2020.

How much has Globe Biomedical raised to-date?

As of Mar 19, 2020, Globe Biomedical has raised a total of $939k (USD).

How many employees does Globe Biomedical have?

Globe Biomedical has 8 employees as of Feb 4, 2024.

Globe Biomedical - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • AI Machinelearning
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Wearabletechnology Healthcare
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified